BNET Industries
Access Pharmaceuticals Inc. (ACCP) is in the Pharma Industry
- Revenue
- Dec 31 2007
- $57.0K
- Profit
- Dec 31 2007
- ($36.6M)
- Market Cap
- Jul 02 2008
- $16.9M
Latest News and Analysis
Hilton to Add 300 Hotels in Asia Over Decade: Report
NEW YORK (Reuters) - Hilton Hotels Corp wants to add 300 hotels to the 47 it operates in Asia in the next decade in a bid to match its rivals and take advantage of a business and leisure travel boom in India and...
Additional Resources
Access Licenses ProLindac™ to Jiangsu Aosaikang Pharmaceutical Co., LTD., a Leading Oncology Pharmaceutical Company for Manufacturing, Development and Commercialization in the Greater China Region
Transaction Value In Excess of $25 Million; Access Gains Second Source Manufacturing And Significant Clinical Trial Support DALLAS and NANJING, PRC, June 4 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (BULLETIN BOARD: ACCP) and Jiangsu Aosaikang Pharmaceutical Co., LTD. ("ASK"), a premier pharmaceutical company focused on bringing...
Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac™ Development at Prestigious International Symposium
ProLindac Demonstrates Sustained and Significant Reductions in Cancer Market CA-125 DALLAS, May 28 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (BULLETIN BOARD: ACCP) announced today that the company gave an invited oral presentation on its lead anticancer compound, ProLindacTM at the International Symposium on Polymer Therapeutics: Laboratory...
Access Pharmaceuticals Presents New Data on the Company's Cobalamin™ Technology at an International Polymer Therapeutics Symposium
DALLAS, May 28 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (BULLETIN BOARD: ACCP) announced today that the company gave oral and poster presentations on its CobalaminTM technology at the International Symposium on Polymer Therapeutics: Laboratory to Clinical Practice, taking place from May 26-28 in Valencia, Spain. The presentations are...
Solara Hires Volman to Augment West Coast Team
Solara, a CommonHealth business unit createdto provide strategic marketing services to improve patient access topharmaceutical brands competing in managed markets, today announced thehiring of Yana Volman as an account supervisor. CommonHealth ( www.commonhealth.com ) is the world's leadinghealthcare-communications network and a WPP (NASDAQ: WPPGY) ( www.wpp.com )company. Ms. Volman will...
Access Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
DALLAS, May 14 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (BULLETIN BOARD: ACCP) announced today that it will make a presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference to be held May 19-20, 2008 at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. Jeffrey...
Access Pharmaceuticals Highlighted in Gene Marcial's New Book '7 Commandments of Stock Investing'
DALLAS, May 5 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (BULLETIN BOARD: ACCP) announced today that renowned business columnist and author Gene Marcial of BusinessWeek has highlighted Access Pharmaceuticals in his recently released investing book titled "7 Commandments of Stock Investing." In a section pertaining to his sixth...
Access Pharmaceuticals Announces New Data on Angiolix®
New Preclinical Data Suggests Potent Anti-Tumor Activity DALLAS, April 17 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (BULLETIN BOARD: ACCP) announced results from preclinical studies ongoing at the prestigious Imperial College London on AngiolixR, a proprietary humanized monoclonal antibody. The new data, presented by Dr. Mahendra Deonarain...
Access Pharmaceuticals Presents New Data on ProLindac™ at the AACR Annual Meeting
- ProLindac demonstrates in vitro superior tumor delivery suggesting efficacy in treating broad range of cancers - DALLAS, April 15 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (BULLETIN BOARD: ACCP) presented a poster yesterday at the 99th Annual Meeting of the American Association for Cancer Research AACR...
Access Pharmaceuticals to Present New Data on ProLindac™ at the AACR Annual Meeting 2008 Conference
DALLAS, April 10 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (BULLETIN BOARD: ACCP) announced today that its collaborators at prestigious institutes in France and Italy will be presenting new preclinical data on its lead anticancer compound, ProLindacTM, at the American Association for Cancer Research AACR Annual Meeting 2008 taking...
CHAT LIVE in the only dedicated CHAT ROOM for Access Pharmaceuticals, Inc. (OTCBB: ACCP) shareholders!
M2 PRESSWIRE-11 March 2008-Stockwire.com: CHAT LIVE in the only dedicated CHAT ROOM for Access Pharmaceuticals, Inc. (OTCBB: ACCP) shareholders!C1994-2008 M2 COMMUNICATIONS LTD RDATE:11032008 AUSTIN, TX -- STOCKWIRE.com, one of the largest investment websites on the internet, is proud to...
Eliminating healthcare disparities in America; beyond the IOM report
Eliminating healthcare disparities in America; beyond the IOM report. Ed. by Richard Allen Williams. Humana Press Inc. 2007 398 pages $59.50 Hardcover RA418 Williams (of the David Geffen School of Medicine at the U....
Nurse practitioners disadvantaged.(NATIONAL)
The first national study into nurse practitioners shows two thirds are extremely limited in their role due to disharmony between state and federal laws. One third of emergency department nurse practitioners, the largest group of NPs, are still awaiting approval to prescribe medications....
ProCom Names Zilligen General Manager and Promotes Rosen
ProCom, a CommonHealth medical educationunit, today announced the promotions of Michael Zilligen to general managerand Lynn Rosen to senior vice president, director of client services. CommonHealth ( www.commonhealth.com ) is the world's leadinghealthcare-communications network and a WPP (NASDAQ: WPPGY) ( www.wpp.com )company. Mr. Zilligen advances from his previous post as...
Correction - Access Highlighted in Recent BusinessWeek Article
DALLAS -- ACCESS PHARMACEUTICALS, INC. (OTC BB: ACCP) announced today that renowned business columnist Gene Marcial of BusinessWeek, highlighted Access Pharmaceuticals in the most recent edition dated September 17, 2007. The article is also available on www.BusinessWeek.com under the 'Inside Wall Street' column. The article focused upon the...
Title: The Countries Of Central And Eastern Europe Represent A Total Pharmaceutical Market Of 286 Million People And A Combined GDP Of US$2.3 Trillion In 2007.
M2 PRESSWIRE-9 July 2007-Research and Markets: Title: The Countries Of Central And Eastern Europe Represent A Total Pharmaceutical Market Of 286 Million People And A Combined GDP Of US$2.3 Trillion In 2007C1994-2007 M2 COMMUNICATIONS LTD RDATE:09072007 Dublin: Research and Markets ...
The Countries of Central and Eastern Europe Represent a Total Pharmaceutical Market of 286 Million People and a Combined GDP Of US$2.3 Trillion in 2007
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c62045) has announced the addition of "The Outlook for Pharmaceuticals in Central & Eastern Europe" to their offering. The impact of EU accession on the pharmaceutical market In May 2004, five of the CEE markets in question joined the European...
Solara Hires Greenblatt to Expand West Coast Business
PARSIPPANY, N.J. -- Solara, a CommonHealth business unit created to provide strategic marketing services to improve patient access to pharmaceutical brands competing in managed markets, today announced the hiring of Joshua Greenblatt as senior vice president, enterprise lead. CommonHealth (www.commonhealth.com) is the world's leading healthcare-communications network and a...
Alerts: Turning Pennies into dollars: (OTCBB: GOFH),(AMEX: GST), (OTCBB: ACCP), (AMEX: RIV).
M2 PRESSWIRE-2 May 2007-RealPennies: Alerts: Turning Pennies into dollars: (OTCBB: GOFH),(AMEX: GST), (OTCBB: ACCP), (AMEX: RIV).C1994-2007 M2 COMMUNICATIONS LTD RDATE:02052007 RealPennies.com ALERTS: reporting on dollar volume movers. -- Brought to you by the HagensMedia.com Finance Network -- ...
Speak with other shareholders about: (OTCBB: GOFH),(AMEX: GST), (OTCBB: ACCP), (AMEX: RIV).
M2 PRESSWIRE-1 May 2007-Stockwire.com: Speak with other shareholders about: (OTCBB: GOFH),(AMEX: GST), (OTCBB: ACCP), (AMEX: RIV).C1994-2007 M2 COMMUNICATIONS LTD RDATE:01052007 AUSTIN, TX -- A very interesting indicator to look for is where the money is flowing into. We have a filter...
- Next »
- page 1 of 9
- « Previous
Sort byClose
- Incorporated: 1974
- CEO: Mr. Jeffrey B. Davis
- Employees: 10
Access Pharmaceuticals is a biopharmaceutical company developing products for use in the treatment of cancer, the supportive care of cancer, and other disease states. As of Dec 31 2006, Co.'s key clinical development program for its drug candidate ProLindac? is in Phase II clinical testing. In addition, Co. is developing other drug delivery technologies including Cobalamin?-mediated oral drug delivery and targeted delivery. Together with its subsidiaries, Co. has proprietary patents or rights to three drug delivery technology platforms, including synthetic polymer targeted delivery, cobalamin-mediated delivery, and mucoadhesive liquid technology.
Key Competitors
Access Pharmaceuticals Inc. Company Info
Board of Directors
Mr. J. Michael Flinn
Chairman
Dr. Rosemary Mazanet M.D., Ph
Mr. Steven H. Rouhandeh
Chairman
Dr. Stephen B. Howell M.D.
Mr. Herbert H. McDade Jr.
Mr. Mark V. Alvino
Mr. John J. Meakem Jr.
Mr. Jeffrey B. Davis
Dr. Mark J. Ahn Ph.D.
Dr. Estaban Cvitkovik M.D.
Contact Information
2600 Stemmons Freeway
Suite 176
Dallas, TX
214 905-5100
